Year: 2025
Type: article
Abstract: suppressor cells 9 ) and are critical in the mode of action of approved drugs (eg, NK cells in the context of anti-CD38 monoclonal antibodies 10 ).Finally, to define the methods and create userfriendly tools for standardized and routine assessment of immune age in routine practice.The authors should be commended for taking the first step in such a relevant patient population!Conflict-of-interest disclosure: B.P. reports honoraria for lectures from and participation on advisory boards for Adaptive Biotech,
Source: Blood
Author: Mark B. Leick
Institution: Massachusetts General Hospital
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4416425658